Literature DB >> 25434693

Ameloblastic carcinoma with features of ghost cell odontogenic carcinoma in a patient with suspected Gardner syndrome.

S G Fitzpatrick1, S A Hirsch2, C M Listinsky3, D J-H Lyu4, D A Baur5.   

Abstract

Ameloblastic carcinoma and ghost cell odontogenic carcinoma are rare malignancies arising in odontogenic epithelium within the jaws. Gardner syndrome is a multifaceted autosomal dominant condition, which results in multiple dentofacial anomalies along with premalignant colon polyp formation and tumor formation in the skin and other organs. We report a case of ameloblastic carcinoma with features of ghost cell odontogenic carcinoma and extensive clear cell change and melanin pigmentation in a patient with clinical features of Gardner syndrome. To the best of our knowledge, odontogenic carcinoma arising in a patient with features of Gardner syndrome has not been reported previously. The clinical, radiographic, and histologic features of the case are discussed along with a review of the relevant literature.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25434693     DOI: 10.1016/j.oooo.2014.09.028

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  3 in total

1.  Orthokeratinized Odontogenic Cyst with an Associated Keratocystic Odontogenic Tumor Component and Ghost Cell Keratinization and Calcifications in a Patient with Gardner Syndrome.

Authors:  Prokopios P Argyris; Ioannis G Koutlas
Journal:  Head Neck Pathol       Date:  2016-08-08

2.  Ghost cell odontogenic carcinoma of anterior mandible: A rare case report with review of literature.

Authors:  Gopikrishnan Vijayakumar; Mala Kamboj; Anjali Narwal; Anju Devi
Journal:  J Oral Maxillofac Pathol       Date:  2021-03-19

Review 3.  Ghost cell odontogenic carcinoma with suspected cholesterol granuloma of the maxillary sinus in a patient treated with combined modality therapy: A case report and the review of literature.

Authors:  You Qin; Yanwei Lu; Liduan Zheng; Hong Liu
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.